Get started
Author

Luca Rubino

Observed names: L. Rubino, Rubino, Luca
ORCID: 0009-0009-9851-3691
Observed ORCID: 0009-0009-9851-3691
OpenAlex ID: A5020949898
Macrophage polarization in tumour progression
2008 · Antonio Sica, Paola Larghi, et al. · Seminars in Cancer Biology · 1,279
Tumor Promotion by Tumor-Associated Macrophages
2007 · Chiara Porta, Biswas Subhra Kumar, et al. · Springer eBooks · 98
Cell-specific Regulation of PTX3 by Glucocorticoid Hormones in Hematopoietic and Nonhematopoietic Cells
2008 · Andrea Doni, Giovanna Mantovani, et al. · Journal of Biological Chemistry · 90
PDF
Targeting tumour-associated macrophages
2007 · Antonio Sica, Luca Rubino, et al. · Expert Opinion on Therapeutic Targets · 58
Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature
2021 · Rosanna Asselta, Luca Di Tommaso, et al. · Thoracic Cancer · 15
Tumor-associated macrophages (TAMs) as new target in anticancer therapy
2006 · Alberto Mantovani, Chiara Porta, et al. · Drug Discovery Today Therapeutic Strategies · 14
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors
2012 · Matteo Simonelli, Paolo A. Zucali, et al. · European Journal of Cancer · 13
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study
2015 · Nicola Personeni, Lorenza Rimassa, et al. · Clinical Colorectal Cancer · 12
Tumor-Associated Macrophages
2017 · Antonio Sica, Alessandra Mancino, et al. · Springer eBooks · 11
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications
2016 · Nicola Personeni, Marina Baretti, et al. · Gastric Cancer · 8
PDF
Targeted Therapy for Thymic Epithelial Tumors: A New Horizon? Review of the Literature and Two Cases Reports
2015 · Matteo Simonelli, Paolo A Zucali, et al. · Future Oncology · 7
The PI3K/ERK Dual Inhibitor AEZS-136 Induces ROS-Dependent Necroptotic Cell Death and Exerts Potent Antitumor Effects In NOD/SCID Mice With Hodgkin Lymphoma Cell Line Xenografts
2013 · Silvia L Locatelli, Giuliano G Stirparo, et al. · Blood · 2
Tumor-Associated Macrophages
2011 · Antonio Sica, Alberto Mantovani, et al. · Springer eBooks · 2
Tumor-Associated Macrophages
2015 · Antonio Sica, Alessandra Mancino, et al. · Springer eBooks · 1
The PI3K-δ Inhibitor TGR-1202 In Combination With Brentuximab Vedotin (SGN-35) Synergistically Induces G2/M Phase Arrest and Cell Death Via Inhibition Of Tubulin Polymerization In Hodgkin Lymphoma Cell Lines
2013 · Silvia L Locatelli, Silvia Tartari, et al. · Blood · 1
Expression of folate pathway regulators and pemetrexed (pem) activity in patients (pts) with advanced non-small cell lung cancer (NSCLC).
2012 · Letizia Gianoncelli, Luca Toschi, et al. · Journal of Clinical Oncology · 1
TGFb expression as predictor of outcome in EGFR wild type (WT) metastatic non-small cell lung cancer (NSCLC) patients (PTS) treated with EGFR tyrosine kinase inhibitors (TKIs).
2012 · Giovanna Finocchiaro, Luca Toschi, et al. · Journal of Clinical Oncology · 1
Tumor-Associated Macrophages
2008 · Antonio Sica, Alessandra Mancino, et al. · Springer eBooks · 1
The cancer patient and medical dermo-pigmentation: psychological aspects.
2023 · Vachtsenovanos , Sofia, Rubino, Luca, et al. · Medicina Historica
PDF
To heal and take care: medical micropigmentation and its role in improving body image
2023 · Santi, Pier Luigi, Franchelli, Simonetta, et al. · Medicina Historica
PDF
Dataset related to article "Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature"
2022 · Asselta Rosanna, Di Tommaso, Luca, et al. · Zenodo (CERN European Organization for Nuclear Research)
542 Tivantinib in combination with gemcitabine shows strong antitumor activity on mesothelioma cell lines and cytoskeletal effects via inhibition of actin
2014 · M. Simonelli, P. Zucali, et al. · European Journal of Cancer
Abstract 4711: The PI3K-δ inhibitor TGR-1202 in combination with Brentuximab Vedotin (SGN-35) synergistically induces G2/M phase arrest and cell death via inhibition of tubulin polymerization in Hodgkin lymphoma cell lines
2014 · Silvia L. Locatelli, Silvia Tartari, et al. · Cancer Research
Pharmacodynamic (PD) evaluation of soluble proteins from a phase I trial of lapatinib (L) in combination with sorafenib (S).
2012 · Matteo Simonelli, Paolo Andrea Zucali, et al. · Journal of Clinical Oncology
HER2 amplification, HER2 overexpression,and TOP2A abnormalities in gastroesophageal cancers: Do they predict responsiveness to epirubicin-based chemotherapy?
2012 · Nicola Personeni, Silvia Bozzarelli, et al. · Journal of Clinical Oncology
Works count: 26
Citation count: 1,606
H-index: 9
I10-index: 9
Year
Topic
Type